Table 1 Pharmacokinetic parameters of baicalin and geniposide in CG and MG rats after intravenous administration of QKLI.
Pharmacokinetic parameters | Baicalin | Geniposide | ||
---|---|---|---|---|
CG | MG | CG | MG | |
t1/2 (h) | 2.131 ± 1.389 | 1.541 ± 0.903 | 1.510 ± 1.510 | 1.229 ± 0.665 |
tmax (h) | 0.5 | 0.5 | 0.5 | 0.5 |
Cmax (ng/mL) | 97.372 ± 20.081 | 215.313 ± 74.120** | 50.348 ± 23.899 | 70.081 ± 24.863* |
AUC0-t (h·ng/mL) | 83.114 ± 30.364 | 195.187 ± 73.973** | 42.553 ± 30.721 | 70.324 ± 30.291* |
AUC0-∞ (h·ng/mL) | 89.644 ± 39.257 | 212.450 ± 102.092** | 45.019 ± 36.711 | 72.959 ± 30.230* |
MRT0-t (h) | 0.979 ± 0.136 | 1.047 ± 0.307 | 0.894 ± 0.123 | 1.125 ± 0.253 |
MRT0-∞ (h) | 1.449 ± 0.616 | 1.434 ± 0.968 | 1.131 ± 0.534 | 1.363 ± 0.420 |